US 12303551
Cellular immunotherapy compositions and uses thereof
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12303551 (Cellular immunotherapy compositions and uses thereof) held by Cero Therapeutics Holdings, Inc. expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cero Therapeutics Holdings, Inc.
- Grant date
- Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K35/17, A61K38/177